Rosty Raykov - Dec 28, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Rostislav Raykov
Stock symbol
FENC
Transactions as of
Dec 28, 2023
Transactions value $
-$15,070
Form type
4
Date filed
12/29/2023, 04:30 PM
Previous filing
Nov 9, 2023
Next filing
Apr 3, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $13.6K +8.54K +3.02% $1.59 291K Dec 28, 2023 Direct F1
transaction FENC Common shares Sale -$42.2K -3.66K -1.26% $11.55 287K Dec 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Commons Shares Options Exercise $13.6K +8.54K +3.24% $1.59 272K Dec 28, 2023 options 8.54K $1.59 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.
F2 Shares sold to satisfy tax obligation on option exercise.
F3 Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024.